Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Management of motor complications in Parkinson disease: current and emerging therapies.

Espay AJ.

Neurol Clin. 2010 Nov;28(4):913-25. doi: 10.1016/j.ncl.2010.03.014. Review.

PMID:
20816270
2.

Treatments for Parkinson disease--past achievements and current clinical needs.

Poewe W.

Neurology. 2009 Feb 17;72(7 Suppl):S65-73. doi: 10.1212/WNL.0b013e31819908ce. Review.

PMID:
19221317
3.

Treatment of levodopa-induced motor complications.

Stocchi F, Tagliati M, Olanow CW.

Mov Disord. 2008;23 Suppl 3:S599-612. doi: 10.1002/mds.22052. Review.

PMID:
18781681
4.

A walk through the management of Parkinson s disease.

Lim E.

Ann Acad Med Singapore. 2005 Mar;34(2):188-95. Review.

5.

Off spells and dyskinesias: pharmacologic management of motor complications.

Khan TS.

Cleve Clin J Med. 2012 Jul;79 Suppl 2:S8-13. doi: 10.3949/ccjm.79.s2a.02. Review.

PMID:
22761271
6.

Other pharmacological treatments for motor complications and dyskinesias.

Waters C.

Mov Disord. 2005;20 Suppl 11:S38-44. Review.

PMID:
15822104
7.

Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations.

Bhidayasiri R, Ling H.

J Med Assoc Thai. 2009 Jan;92(1):142-54. Review.

PMID:
19260256
8.

Myths and realities of continuous dopaminergic stimulation.

Pirtošek Z.

Psychiatr Danub. 2011 Mar;23(1):80-3. Review.

9.

An update on the treatment of Parkinson's disease.

Jankovic J.

Mt Sinai J Med. 2006 Jul;73(4):682-9. Review.

PMID:
16878274
10.

Current and experimental treatments of Parkinson disease: A guide for neuroscientists.

Oertel W, Schulz JB.

J Neurochem. 2016 Oct;139 Suppl 1:325-337. doi: 10.1111/jnc.13750. Epub 2016 Aug 30. Review.

11.

Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.

Melamed E, Zoldan J, Galili-Mosberg R, Ziv I, Djaldetti R.

J Neural Transm Suppl. 1999;56:173-83. Review.

PMID:
10370911
12.

Treatment of Parkinson's disease: levodopa as the first choice.

Katzenschlager R, Lees AJ.

J Neurol. 2002 Sep;249 Suppl 2:II19-24. Review.

PMID:
12375059
13.

Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease.

Wolters ECh.

Parkinsonism Relat Disord. 2007 Sep;13 Suppl:S18-23. Epub 2007 Aug 16. Review.

PMID:
17702631
14.

[Advances in the medical treatment of Parkinson's disease].

Chaná P.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S22-5. doi: 10.1016/S1353-8020(09)70773-4. Review. Spanish.

PMID:
20082996
15.

Treatment of Parkinson's disease.

Hely MA, Fung VS, Morris JG.

J Clin Neurosci. 2000 Nov;7(6):484-94. Review.

PMID:
11029227
16.

Dyskinesias and grip control in Parkinson's disease are normalized by chronic stimulation of the subthalamic nucleus.

Wenzelburger R, Zhang BR, Poepping M, Schrader B, Müller D, Kopper F, Fietzek U, Mehdorn HM, Deuschl G, Krack P.

Ann Neurol. 2002 Aug;52(2):240-3.

PMID:
12210799
17.

Parkinson's disease: diagnosis and treatment.

Rao SS, Hofmann LA, Shakil A.

Am Fam Physician. 2006 Dec 15;74(12):2046-54. Review.

18.

Recent developments in the pharmacological treatment of Parkinson's disease.

Tuite P, Riss J.

Expert Opin Investig Drugs. 2003 Aug;12(8):1335-52. Review.

PMID:
12882620
19.

Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.

Olanow CW.

Mov Disord. 2008;23 Suppl 3:S613-22. doi: 10.1002/mds.22061. Review.

PMID:
18781663
20.

Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.

Stocchi F, Ruggieri S, Vacca L, Olanow CW.

Brain. 2002 Sep;125(Pt 9):2058-66.

PMID:
12183351

Supplemental Content

Support Center